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 Previous findings from a state-wide Iodine Deficiency Disorders (IDD) study 
among pregnant women (PW) in Sarawak indicated that PW are at risk of 
IDD and further study is needed. This paper describes the methodology used 
in conducting this study on assessment of risk of iodine deficiency among 
pregnant women in Sarawak, Malaysia. Thirty maternal child health care 
clinics (MCHCs) were selected using probability proportional to population 
size (PPS) sampling technique. The PW sample size was calculated based on 
95% confidence interval (CI), relative precision of 5%, design effect of 2, 
anticipated IDD prevalence of 65.0% and non-response rate of 20%.  
Thus, the total sample size required was 750 (25 respondents per selected 
MCHC). The WHO Expanded Programme on Immunization (EPI) surveys 
approach was used to randomly select the first respondent and subsequent 
respondents were chosen until the required number of PW was met. The 
required data were obtained through: face-to-face interviews  
(socio-demographic and food frequency questionnaire), clinical assessments 
(thyroid size, and hyper/hypothyroidism) and biochemical analysis  
(urine and blood serum). A total of 677 PW responded in the study with  
a response rate of 90.2%. Majority of the PW were at second gravida,  
aged 25-29 years old and of Malay ethnicity. The methodology used in this 
study was based on international guidelines which may provide state’s 
estimates. All the necessary steps were taken into consideration to ensure 
valid and reliable findings on current iodine status among PW. 
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1. INTRODUCTION  
Iodine, an essential nutrient for thyroid hormone thyroxine (T4) and triiodothyronine (T3) 
production, is essential for normal growth and development [1]. Adequate iodine intake is essential for the 
production of thyroid hormones. The body of a healthy adult contains about 10-20 mg of iodine which on 
average 70-80% (8-15 mg of iodine) is stored in thyroid gland [2]. The recommended daily iodine intake 
criteria for pre-school children, adults and pregnant women are 90 ug/day, 150 ug/day and 250 ug/day, 
respectively [3]. Insufficient supply of iodine results in inadequate thyroid hormone production which may 
have multiple effects on human growth and development, collectively termed iodine deficiency  
disorders (IDD) [4]. 
Worldwide, IDD is a major public health problem which affects human population from early foetal 
life to adulthood [5]. IDD can affect anyone of any age, with the most vulnerable high-risk group for IDD in 
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pregnant women (PW) [6]. Iodine requirement is high during pregnancy,  
it may increase by 50% due to physiological changes and increased in maternal thyroxine production [7].  
Severe and long-term iodine deficiency in PW results in serious adverse effects such as increasing risk of 
stillbirths, abortions and congenital abnormalities [8]. However, this problem can be corrected by mass 
application of iodized salt [9], also known as universal salt iodization (USI). Since the largest part of iodine 
intake is usually from household salt [10], USI is the optimal way to ensure sufficient intake of iodine by all 
individuals [11], and the international experience has convincingly demonstrated that USI is the most 
reliable, safe and cost-effective way to eliminate IDD [12]. Normally, an average daily salt intake in 
population ranged between 5-15g/day may provide approximately 150 µg of iodine/day after taking into 
account the lose of iodine in iodized salt due to climatic and storage factors [13]. 
In Sarawak, IDD is common in most of its interior areas due to the predominantly mountainous 
terrain and heavy rain. However, with rapid ongoingsocio-economic development over the past 20 years and 
the emerging of new townships, outside foods including seafood are now more widely available to the once 
remote and inaccessible areas [14-15]. In 2008, a National IDD survey conducted in Malaysia revealed the 
median urinary iodine concentration (mUIC) of school children in Sarawak was at borderline-adequate level 
(101.9 µg/L), and iodine status among children from rural areas remains inadequate (mUIC, 96.6 µg/L) [16]. 
Hence, within the same year, a legislation on USI was enacted in Sarawak which required all salt for human 
consumption to be iodized with iodine content of 20 ppm to 40 ppm [17].  
In 2015, a state-wide IDD study among pregnant women (PW) in Sarawak revealed an inadequate 
iodine status among the study participants despite the implementation of the mandatory USI since 2008.  
The mUIC of the PW in this study was 105.6 µg/L, indicating iodine deficiency and the distribution of 
urinary iodine (UI) levels showed that a total of 330 PW (65.0%) had UIC<150 µg/L [18]. The present 
findings which reported that PW residing in areas where people generally have sufficient iodine intake may 
still experience IDD were in concordance with those of other studies[19-22].  
Thus, a comprehensive study is warranted to provide Sarawak State Health Department (SSHD) with more 
relevant information on the current status of IDD among pregnant women in Sarawak after ten years of 
mandatory USI implementation since 2008. This article aims to describe the methodology used in conducting 
this study on assessment of risk of iodine deficiency among pregnant women in Sarawak, Malaysia. 
 
 
2. RESEARCH METHOD  
2.1. Scope of the study 
The state-wide assessment of risk of iodine deficiency among pregnant women (PW) in Sarawak, 
Malaysia was a collaborative study between Institute for Public Health, National Institutes of Health, 
Ministry of Health Malaysia and the Sarawak State Health Department (SSHD), Ministry of Health Malaysia. 
The survey was targeted to pregnant women in the first trimester who registered and received antenatal care 
in government maternal child health care clinics (MCHCs). 
 
2.2. Sampling frame and sample size 
The sampling frame used was the 2016 list of all the government MCHCs in Sarawak. Based on the 
frame, there were 267 MCHCs in the state. The sampling did not include PW from private hospitals.  
The sampling units for the survey were all the MCHCs in the 12 divisions in Sarawak. A total of 30 MCHCs 
were considered sufficient (recommended minimum number of cluster to ensure a relatively valid prevalence 
estimate) due to limited resources and logistics feasibility [3]. These MCHCs were selected based on 
probability proportional to size (PPS) method which involved 4 steps: i. Listing the MCHCs to be sampled, 
ii. Writing the population size (based on total post-natal mother visit to MCHCs in 2016). iii. Cummulating 
this size measures, and iv. Taking systematic random sample of the required size from the cummulated  
list [23]. The PW sample size was calculated using an appropriate formula on the basis of the ability to 
estimate the prevalence of IDD with adequate precision, and was inflated to cater for estimated design effect 
and non-response [24-25]. The sample size of the study was calculated based on 95% confidential interval 
(CI), relative precision of 5%, design effect of 2 and non-response rate of 20%. The anticipated prevalence of 
IDD for the Sarawak was 65.0%, based on the prevalence reported, the total sample size required was 737  
(round up to 750). Therefore, the sample size per MCHC will be 25 (750/30=25). The sample size also 
exceeds the WHO recommended sample size of 300 for reliable assessment of iodine status of  
population [26]. The WHO Expanded Programme on Immunization (EPI) surveys approach was used to 
randomly select the first respondent and then, subsequent respondents were chosen until the required number 
of PW was met [23]. The inclusion criteria for participation in this study included PW of first trimester  
(first 12 weeks of gestation), aged 18 years and above, and were attending antenatal care appointments at the 
30 selected MCHCs between 15 July 2018 and 15 October 2018. 
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2.3. Study instrument 
All required data were obtained through: interviews on mother’s socio-demographic and food 
frequency intake, thyroid size examination, hyper/hypothyroidism assessment and analysis of urine iodine, 
blood serum and household salt from the study respondents. The face-to-face interview of IDD survey 
questionnaires took approximately 30 minutes to complete. 
 
2.4. Socio-demographic and food frequency intake 
The demographic questionnaire included questions related to personal information such as age, 
gender and ethnicity. The consumption patterns of iodine-rich foods over the past one month (daily, weekly 
and monthly) were measured using semi-quantitative food frequency questionnaire (FFQ) adopted from the 
National IDD Survey 2008 [16]. It included 11 iodine-rich food items such as fish and fish products, other 
seafood and seaweed, 7 goitrogen-rich food items such as tubers and cabbage. A food album containing 
pictures of commonly eaten iodine-rich food were used to help the respondents identify the food items.  
Household utensils such as cup and spoon were also used to help the respondents quantify the amount of  
food taken. 
 
2.5. Thyroid size 
Enlargement of the thyroid gland in PW was assessed by the trained staff nurses and graded 
according to grade 0, 1 and 2 [3]. Grade 0; no goitre, grade 1; an enlarged thyroid that is palpable but not 
visible when the neck is in the normal position. Grade 2, a swelling in the neck that is visible when the neck 
is in a normal position. A prevalence rate of 0-4.9 is considered as none, 5.0%-19.9% as mild, 20.0%-29.9% 
as moderate, ≥30.0% as severe IDD [3]. 
 
2.6. Iodine in urine 
Spot urine samples were collected using urine containers from all the respondents by trained 
medical laboratory assisstants. The samples were kept in the polystyrene container before trasported to the 
IDD Laboratory in Kota Kinabalu, Sabah. The samples were stored at-18oC until analysis. Urinary iodine 
determination was done using in-house modified microplate method based on manual digestion with 
ammonium persulfate followed by the calorimetric determination of the Sandel-Kolthoff reaction by using 
96-multiwell plates and an absorbance microplate reader at 405 nm [27]. PW with urinary iodine 
concentration (UIC) of <150, 150–249, 250–499, and ≥500 g/L were considered as having insufficient, 
adequate, more than adequate, or excessive iodine levels, respectively [3]. 
 
2.7. Iodine in blood 
Venous blood samples (10.0 ml) were collected into plain vacutainer tubes by trained staff nurses. 
Then, the blood serum was separated and kept in-200C freezer at the nearby hospital laboratory at the end of 
the day by medical laboratory assisstants. All samples were properly packed and labeled, kept in polystyrene 
boxes containing ice before being transported to the private laboratory in Sarawak for further analysis.  
The Thyroid Stimulating Hormone (TSH) status was determined by using commercial Architect  
TSH 7K62 [28]. Free T4 and free T3 status were determined using commercial Architect Free Thyroxine  
(free T4) 7K65 [29] and Architect Free Triiodothyronine (free T3) 7K63 [30], respectively. Thyroperoxidase 
antibody (TPOAb) status was determined using commercial Architect Anti-TPO 2K47 [31]  
and Thyroglobulin antibody (TGAb) status was determined using commercial Architect Anti-Tg 2K46 [32]. 
Normal reference ranges established by the commercial kit manufacturer were used for assessing thyroid 
dysfunction: TSH (0.35-4.94 mIU/L, free T4 (9.0-19.1 pmol/L), free T3 (2.63-5.71 pmol/L), TPOAb  
(<5.61 IU/mL) and TGAb (<4.11 IU/mL) [28-32]. 
 
2.8. Iodine in salt 
All the PW were also asked to bring approximately 80g of salt from their respective homes in  
self-sealing polythene bags. The samples were properly packed and labeled before being transported to the 
Nutrition Unit, Institute for Medical Research, Kuala Lumpur for analysis. The presence of iodine in salt was 
tested using rapid test kits (RTKs) developed by Institute for Medical Research. While, the level of iodine 
concentration in salt was determined using iodimetric titration method [33]. Titration is one of the most 
accurate analytical methods available and this ‘gold standard’ analytical method is recommended for factory 
quality assurance and in research studies [34]. Households coverage with iodized salt and monitoring quality 
of salt iodization are important key indicators in the implementations of USI programs. To ensure sustainable 
IDD programme in a country, it is recommended that at least 90% of households using adequately iodised 
salt which contains 15 parts per million or more [3]. 
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2.9. Anthropometric measurements 
Anthropometric measurements were weight (kg) and height (cm). TANITA HD-319 digital 
weighting equipment was used to measure body weight to the nearest 0.1 kg. Without wearing shoes, 
respondents are required to stand upright, head and eyes straight. While, the measurement for height were 
taken to the nearest 0.1 cm using SECA 213 portable stadiometer. The respondents were required to stand 
upright without shoes, hips and shoulders in a straight line, head and eye is straight. Measurements were done 
in duplicate, and the mean was recorded as the final reading. Body mass index (BMI) was calculated by 
weight in kilograms divided by height in metres squared. The term underweight refers to BMI<18.5 kg/m2, 
normal (BMI=18.5–24.9 kg/m2), while overweight and obese are classified as having BMI  
within 25.0–29.9 kg/m2 and ≥30 kg/m2, respectively [35]. 
 
2.10. Hyper/hypothyroidism assessment 
Staff nurse of the data collection team carried out face-to-face interviews with the PW and 
conducted physical assessment to gather information on hyper/hypothyroidism status. This assessment 
consists of 12 items which covered: a) Proximal muscle weakness/hyper-reflexia. b) Warm/Sweat palms.  
c) Hand sweating. d) Fine tremours (finger). e) Lid retraction/lid lag. f) Resting tachycardia.  
g). Apathy/lethargy. h). Facial puffiness. i). Slow speech. j) Hoarse voice. k) Cold intolerance. l) Fat/obese, 
and m) Constipation. 
 
2.11. Field implementation and ethical consideration 
Approval was obtained from the Medical Research and Ethic Committee, Ministry of Health 
Malaysia (NMRR-17-2932-39316) and the head of department in all respective MCHCs. A total of 12 data 
collection teams were formed, and in each team, one nutritionist as team leader and assisted by 2 staff nurses 
and one medical laboratory assisstant. A training course was conducted to familiarize the teams with the 
questionnaire used and samples collection techniques. Information sheets and consent forms were made 
available for every respondent. All individual information was kept confidential. A dummy identification was 
given to each respondent instead of his or her name to make sure the study was anonymous. 
 
2.12. Quality control 
Quality control of the whole survey was done at various stages of the study to ensure data collected 
was of high-quality. During field data collection, team leader was given responsibility to conduct the 
interviews and was given responsibility to supervise the whole data collection processes. At the central level, 
the progress of data collection for all MCHCs was monitored closely by the officer from the Institute for 
Public Health on a weekly basis. In addition, all the submitted questionnaires had undergone various checks 
by the data processing team. 
 
2.13. Data entry and analysis 
All data entry activities were centralized at Institute for Public Health which started from receiving 
questionnaire from the field until hand over of the clean dataset to data analysis team. Data processing 
activities were done based on the type of questionnaire. The data entry was done using an excel database by 
data puncher. All data that were keyed into database were verified by a verifier. SPSS version 21 was used 
for data analysis. The data was then checked and cleaned for quality control purposes. Descriptive statistic 
was used to illustrate the social demographic of the respondents. Analysis was done according to the 
objectives of the study. Complex sample analysis procedures were used in the analysis and was carried out at 
95% confidence interval. 
 
 
3. RESULTS AND DISCUSSIONS  
All selected MCHCs participated in the survey (100% response rate) and a total of 677 respondents 
responded to the survey, with an overall response rate of 90.2%. Out of 30 MCHCs surveyed, a total of 21 
MCHC observed a better response rate of 100%. However, there were a few MCHCs showed a response rate 
of less than 50% such as KK Batu Kawa (40%), KK Spaoh (44%), KK Asajaya (48%), and KK Tatau (48%) 
as shown in Table 1. 
The respondents comprised of 677 PW aged between 18 to 45 years (mean±SD, 28.6±5.3) and 
approximately 35% of the respondents were from age group 25–29 years old. By ethnicity, majority of the 
respondents were Malays (35.2%), followed by Iban (29.5%) and Chinese (13.0%). In terms of gravida 
(number of pregnancy), about 31% of PW were in their second gravida and 28.5% were in their first gravida 
as shown in Table 2. 
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Table 1. Number of respondents responsed to the survey, by Division and MCHCs 
division & MCHCs 
number of respondents percentages 
(%) invited response 
Kuching 
KK Petra Jaya 
KK Batu Kawa 
MCHC Sekama 
MCHC Gita 
KK Kota Sentosa 
KKIA Kota Padawan 
Samarahan 
KK Kota Samarahan 
MCHC Sebisak 
K1M Samarindah 
KK Asajaya 
Serian 
KK Siburan 
KK Serian 
Sri Aman 
KK Sri Aman 
Betong 
KK Kabong 
KK Spaoh 
Sarikei 
KK Bintangor 
KK Sarikei 
Mukah 
KKIA Dalat 
Sibu 
KK Jalan Oya 
KK Lanang 
KKIA Kanowit 
Kapit 
KK Kapit 
KK Song 
Bintulu 
KK Bintulu 
KK Tatau 
Miri 
KK Tudan 
KKIA Miri 
KKIA Tmn Tunku 
Limbang 
KKIA Limbang 
KK Lawas 
 
25 
25 
25 
25 
25 
25 
 
25 
25 
25 
25 
 
25 
25 
 
25 
 
25 
25 
 
25 
25 
 
25 
 
25 
25 
25 
 
25 
25 
 
25 
25 
 
25 
25 
25 
 
25 
25 
 
24 
10 
25 
25 
25 
25 
 
25 
25 
15 
12 
 
25 
25 
 
25 
 
25 
11 
 
25 
25 
 
25 
 
25 
25 
25 
 
25 
18 
 
25 
12 
 
24 
26 
25 
 
25 
25 
 
96.0 
40.0 
100.0 
100.0 
100.0 
100.0 
 
100.0 
100.0 
60.0 
48.0 
 
100.0 
100.0 
 
100.0 
 
100.0 
44.0 
 
100.0 
100.0 
 
100.0 
 
100.0 
100.0 
100.0 
 
100.0 
72.0 
 
100.0 
48.0 
 
96.0 
104.0 
100.0 
 
100.0 
100.0 
Total 750 677 90.2 
 
 
In conducting a state-wide survey among PW in Sarawak, sampling from government MCHCs was 
considered the best feasible approach to obtain a representative sample of PW in Sarawak. Based on the 
Ministry of Health, Malaysia annual report, the number of government MCHCs represents about 98% of all 
the MCHCs in Sarawak and, the delivery rate in government MCHCs was more than 95% [18]. With this 
high rates, a representative sample of PW in Sarawak can be obtained from the government MCHCs. Due to 
the small proportion of private MCHCs in Sarawak, we decided to exclude private MCHCs in the survey and 
this exclusion would not make any significant effect on the findings. The strength of the study is the use of 
appropriate sampling method which involved a representative sample of respondents from all divisions in 
Sarawak. The samples size calculation also take into consideration of few factors such as prevalence,  
margin of error, design effect and estimated response rate [25]. The response rate of 90.2% in this study was 
considered high. The good response rate could be due to several factors including good collaborations and 
supports from Sarawak State Health Department (SSHD). In addition, the data collection was conducted by 
SSHD staffs who are well verse with the local language and culture. However, there were a few MCHCs 
showed low response rates, especially from small MCHCs. It’s noted that during the period of data 
collection, in these MCHCs with low response rates, there has been quite a number of PW whose gestational 
periods has been exceeding 12 weeks (first trimester) when they came for check up. Thus, they are not 
eligible for the survey. 
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Table 2. Socio-demographic characteristics of pregnant women in Sarawak 
characteristics number of respondents percentages (%) 
Overall 677 100.0 
Age (years) 
≤25 
25-29 
30-34 
≥35 
 
178 
232 
188 
79 
 
26.3 
34.3 
27.8 
11.7 
Ethnicity 
Iban 
Malay 
Chinese 
Bidayuh 
Melanau 
Others 
 
200 
238 
88 
49 
41 
61 
 
29.5 
35.2 
13.0 
7.2 
6.1 
9.0 
Gravida (number of pregnancy) 
1 
2 
3 
≥4 
 
193 
208 
130 
146 
 
28.5 
30.7 
19.2 
21.6 
 
 
4. CONCLUSION  
This IDD study among PW aimed at providing population-based data on the IDD status of PW in 
Sarawak. The survey was planned with the goal of obtaining the latest data to support Ministry of Health, 
Malaysia in reviewing and planning the IDD program in Sarawak. To ensure the data collected are of high 
quality and validity, all the necessary steps have been taken, starting from planning, determination of sample 
size, sampling design, data collection techniques, and quality control of data collected. The findings of this 
study will enable the Ministry of Health, Malaysia to evaluate the impact of the USI among pregnant women 
in Sarawak and make necessary improvement to the present national programme. 
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